Nitrosamine Testing for Antidepressants and SSRIs: NDSRI Risk Assessment and CRO Services
Introduction Nitrosamine Testing for Antidepressants and SSRIs is a specialized analytical and regulatory process designed to detect, quantify, and control […]
Nitrosamine Testing for Antibiotics and Beta-Lactam APIs: Structural Risks and Analytical Approach
Introduction Nitrosamine Testing for Antibiotics and Beta-Lactam APIs is a specialized analytical mandate focused on the detection, identification, and quantification
Nitrosamine Risk in Drug-Drug Combination Products: How Multiple APIs Amplify Formation Risk
Introduction Nitrosamine Risk in Drug-Drug Combination Products has emerged as a significant toxicological challenge because combining multiple active pharmaceutical ingredients
Nitrosamines from Excipients: How Common Pharmaceutical Excipients Contribute to Nitrosamine Formation Risk
Introduction Nitrosamines from Excipients primarily arise when trace levels of nitrite impurities present in inactive formulation components react with susceptible
Nitrosamine Control Strategy Development Services: From Risk Assessment to Regulatory Submission
Introduction Nitrosamine Control Strategy Development Services offer a comprehensive, science-driven framework for identifying, quantifying, and controlling mutagenic N-nitroso impurities throughout
Nitrosamine Testing for Injectable Drug Products: Parenteral Formulation Challenges and Regulatory Requirements
Introduction: Implementation of Nitrosamine Testing for Injectable Drug Products is a critical safety and regulatory requirement because parenteral drug products
When Should You Start Nitrosamine Risk Assessment in Your Drug Development Program?
Introduction A formal nitrosamine risk assessment should begin during the preclinical stage of development, specifically during candidate selection and the
When Should You Start Nitrosamine Risk Assessment in Your Drug Development Program? Read More »
Case Study: Nitrosamine Risk Assessment and Confirmatory LC-MS/MS Testing for a Metformin Generic
The Critical Role of Nitrosamine Testing for a Metformin Generic Nitrosamine Testing for a Metformin Generic is a critical regulatory
Do All Drug Products Need a Nitrosamine Risk Assessment? FDA’s Risk-Based Approach Explained
Assessing the chemical safety of human drug products requires a thorough understanding of potential mutagenic and carcinogenic impurities that fall
Nitrosamine Risk Assessment and Testing Services for NDA and BLA Submissions
Introduction: Nitrosamine impurities are among the most scrutinized safety concerns in modern pharmaceutical development, and no NDA or BLA submission
Nitrosamine Risk Assessment and Testing Services for NDA and BLA Submissions Read More »